van Bergen En Henegouwen PMP - Search Results

1

Nanobody-Targeted Photodynamic Therapy: Nanobody Production and Purification.

Mashayekhi V, Schooten E, van Bergen En Henegouwen PMP, Kijanka MM, Oliveira S. Mashayekhi V, et al. Among authors: van bergen en henegouwen pmp. Methods Mol Biol. 2022;2451:481-493. doi: 10.1007/978-1-0716-2099-1_21. Methods Mol Biol. 2022. PMID: 35505026

2

Molecular biology of epidermal growth factor receptor inhibition for cancer therapy.

Oliveira S, van Bergen en Henegouwen PM, Storm G, Schiffelers RM. Oliveira S, et al. Expert Opin Biol Ther. 2006 Jun;6(6):605-17. doi: 10.1517/14712598.6.6.605. Expert Opin Biol Ther. 2006. PMID: 16706607 Review.

3

Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy.

van der Veeken J, Oliveira S, Schiffelers RM, Storm G, van Bergen En Henegouwen PM, Roovers RC. van der Veeken J, et al. Curr Cancer Drug Targets. 2009 Sep;9(6):748-60. doi: 10.2174/156800909789271495. Curr Cancer Drug Targets. 2009. PMID: 19754359 Review.

4

Downregulation of EGFR by a novel multivalent nanobody-liposome platform.

Oliveira S, Schiffelers RM, van der Veeken J, van der Meel R, Vongpromek R, van Bergen En Henegouwen PM, Storm G, Roovers RC. Oliveira S, et al. J Control Release. 2010 Jul 14;145(2):165-75. doi: 10.1016/j.jconrel.2010.03.020. Epub 2010 Mar 31. J Control Release. 2010. PMID: 20362020

5

Nanobody-shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targeting.

Talelli M, Rijcken CJ, Oliveira S, van der Meel R, van Bergen En Henegouwen PM, Lammers T, van Nostrum CF, Storm G, Hennink WE. Talelli M, et al. J Control Release. 2011 Apr 30;151(2):183-92. doi: 10.1016/j.jconrel.2011.01.015. Epub 2011 Jan 22. J Control Release. 2011. PMID: 21262289

6

A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth.

Roovers RC, Vosjan MJ, Laeremans T, el Khoulati R, de Bruin RC, Ferguson KM, Verkleij AJ, van Dongen GA, van Bergen en Henegouwen PM. Roovers RC, et al. Int J Cancer. 2011 Oct 15;129(8):2013-24. doi: 10.1002/ijc.26145. Epub 2011 Aug 8. Int J Cancer. 2011. PMID: 21520037 Free PMC article.

7

Reprint of "Nanobody--shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targeting".

Talelli M, Rijcken CJ, Oliveira S, van der Meel R, van Bergen en Henegouwen PM, Lammers T, van Nostrum CF, Storm G, Hennink WE. Talelli M, et al. J Control Release. 2011 Jul 15;153(1):93-102. doi: 10.1016/j.jconrel.2011.06.003. J Control Release. 2011. PMID: 21684029

8

Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment.

van der Meel R, Oliveira S, Altintas I, Haselberg R, van der Veeken J, Roovers RC, van Bergen en Henegouwen PM, Storm G, Hennink WE, Schiffelers RM, Kok RJ. van der Meel R, et al. J Control Release. 2012 Apr 30;159(2):281-9. doi: 10.1016/j.jconrel.2011.12.027. Epub 2011 Dec 29. J Control Release. 2012. PMID: 22227023

9

Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobody.

Oliveira S, van Dongen GA, Stigter-van Walsum M, Roovers RC, Stam JC, Mali W, van Diest PJ, van Bergen en Henegouwen PM. Oliveira S, et al. Mol Imaging. 2012 Feb;11(1):33-46. Mol Imaging. 2012. PMID: 22418026

10

A novel method to quantify IRDye800CW fluorescent antibody probes ex vivo in tissue distribution studies.

Oliveira S, Cohen R, Walsum MS, van Dongen GA, Elias SG, van Diest PJ, Mali W, van Bergen En Henegouwen PM. Oliveira S, et al. EJNMMI Res. 2012 Sep 25;2(1):50. doi: 10.1186/2191-219X-2-50. EJNMMI Res. 2012. PMID: 23009555 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page